Author

Carmen Rivas

Consejo Superior de Investigaciones CientíficasORCID 0000-0002-0518-7199Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Carmen Rivas2 papers · Consejo Superior de Investigaciones Científicas

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Anxo VidaliD· 2 shared Adrián Varela-VázqueziD· 1 shared Alexander Carneiro-Figueira· 1 shared Amanda Guitián‐CaamañoiD· 1 shared Berta L. Sánchez‐LaordeniD· 1 shared Carlos Fernandez-LozanoiD· 1 shared Carmen CarneiroiD· 1 shared Constance AlabertiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anxo VidalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cx43 Enhances Response to BRAF/MEK Inhibitors by Reducing DNA Repair Capacity

Adrián Varela-Vázquez, Amanda Guitián‐Caamaño, Paula Carpintero-Fernández, Alexander Carneiro-Figueira, Vanesa Álvarez, Marta Varela-Eirín, Teresa Calleja-Chuclá, Susana B. Bravo, Anxo Vidal, Juan Sendón-Lago, Marina Rodríguez-Candela Mateos, José Ramón Caeiro, Victoria Sanz‐Moreno, Trond Aasen, Miguel G. Blanco, , María D. Mayán

This study shows that Cx43 enhances the effectiveness of BRAF/MEKi by reducing DNA repair, leading to increased DNA damage and cellular senescence, and proposes a novel therapeutic approach using sEVs.

Nature Communications · Jul 4, 2025Peer-reviewedCancer Biology

Transcriptional repression of SOX2 by p53 in cancer cells regulates cell identity and migration

Patricia Lado‐Fernández, Jéssica M. Vilas, Tânia Fernandes, Carmen Carneiro, Sabela Da Silva‐Álvarez, Valentín Estévez‐Souto, Pablo Pedrosa, Miguel González‐Barcia, Luis E. Abatti, Jennifer A. Mitchell, Carmen Rivas, Gema Moreno‐Bueno, Anxo Vidal, Manuel Collado

This paper shows that TP53 represses SOX2 in cancer cells, affecting cell identity and migration, with implications for metastasis in breast cancer.

International Journal of Cancer · Jun 2, 2025Peer-reviewedCancer Biology